# OnCo record nct04581512 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04581512/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04581512", "NCT04581512" ;
  schema:name "Study to Evaluate the Safety and Tolerability of EP0042"@en ;
  schema:description "A phase 1/2 trial of Venetoclax and Azacitidine in acute myeloid leukaemia, chronic myelomonocytic leukaemia and MDS/MPN overlap neoplasms and myelodysplastic syndromes / neoplasms, run by Ellipses Pharma, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04581512/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04581512> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2020-11-02" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/cmml/>, <https://onco.cc/cancers/mds/> ;
  onco:drugs <https://onco.cc/drugs/venetoclax/>, <https://onco.cc/drugs/azacitidine/> ;
  onco:companies <https://onco.cc/companies/ellipses-pharma/> .